EPOGEN A review of the FDA database found that 1329 AE reports have been received for Epogen as of[removed]Of these 20 are for the age group O-9 and 35 are for ages IO- 19. While the total reports have a slight female

First Page		Document Content
Erythropoiesis-stimulating agents Growth factors COSTART Epoetin alfa Eosinophilia Myalgia Urticaria Leukocytosis Medicine Hematology Health		EPOGEN A review of the FDA database found that 1329 AE reports have been received for Epogen as of[removed]Of these 20 are for the age group O-9 and 35 are for ages IO- 19. While the total reports have a slight female Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 46,90 KB Share Document on Facebook

	DENVER, COStart of season: End of Season: DocID: 1rJ82 - View Document
	DENVER, COStart of season: End of Season: DocID: 1nph5 - View Document
	Microsoft Word - JWE80031.DOC DocID: NEwk - View Document
	Blue Ribbon Panel 8 - Scope of MedDRA Background MedDRA was developed by ICH as a standardized medical terminology to facilitate sharing of regulatory information internationally for medical products used by humans. The DocID: Mg1Z - View Document
	Blue Ribbon Panel MedDRA and Product Labeling: Best Practices 16 March 2004 AstraZeneca Zoetermeer, Netherlands DocID: LI8R - View Document